National Bank of Canada
ANAB icon

National Bank of Canada’s AnaptysBio ANAB Stock Holding History

National Bank of Canada’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540 Buy
+8
New +$485 ﹤0.01% 2846

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

National Bank of Canada's ANAB Position: Q2 2026 in Review

National Bank of Canada opened a new position in AnaptysBio (ANAB) in Q2 2026: 8 shares worth $540. The stake represents ﹤0.01% of the portfolio and ranks #2846 among its holdings.

213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • National Bank of Canada held 8 shares of AnaptysBio worth $540 as of Q2 2026.
  • AnaptysBio was a new National Bank of Canada position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2846 holding.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.